SYKStock
Verdicts genuinely change. Free email alert the moment SYK's does — no target price to set, unlike a price alert.
Near limit Ratio screen, 7 of 7 decided standards passing. FTSE Shariah, MSCI Islamic, Usmani are within 3 points of their line. Even if they all crossed, the majority verdict would stay Compliant. What would change it
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Trade plan
Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
SYK is currently considered halal (Sharia-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.
This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →
How the status reached this point
Compliant · status tracked since Nov 17, 2026
No change to SYK’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.
Read once a day from our own screen, last on Nov 17, 2026. The per-methodology record is under “What changed, and when” in the in-house research.
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2026-06-30. These ratios come from the issuer's own published statements rather than structured SEC data.
AAOIFI divides by the market cap: $106.0B as of 2026-09-09. At the 2026-11-18 close it is about $122.2B (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 12.6% (14.6% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 2.8% (3.2% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.
Business activity: cleared (no excluded categories detected)
AAOIFI Pass 3 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 14.57% | 30.00% | Pass(15.4pp buffer) |
| Interest-bearing investments | 3.20% | 30.00% | Pass(26.8pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
Usmani Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 32.23% | 33.00% | Pass(0.8pp buffer) |
| Interest-bearing investments | 7.07% | 33.00% | Pass(25.9pp buffer) |
| Non-liquid assets | 85.12% | at least 20.00% | Pass(65.1pp above the floor) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
MSCI Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 32.23% | 33.33% | Pass(1.1pp buffer) |
| Cash + interest-bearing securities | 7.07% | 33.33% | Pass(26.3pp buffer) |
| Accounts receivable | 14.88% | 33.33% | Pass(18.4pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
FTSE Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 31.17% | 33.33% | Pass(2.2pp buffer) |
| Cash + interest-bearing securities | 7.07% | 33.33% | Pass(26.3pp buffer) |
| Accounts receivable | 14.88% | 50.00% | Pass(35.1pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
Dow Jones Islamic Market Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 13.29% | 33.00% | Pass(19.7pp buffer) |
| Cash + interest-bearing securities | 2.92% | 33.00% | Pass(30.1pp buffer) |
| Accounts receivable | 3.22% | 33.00% | Pass(29.8pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
S&P Shariah Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 13.59% | 33.00% | Pass(19.4pp buffer) |
| Cash + interest-bearing securities | 2.98% | 49.00% | Pass(46.0pp buffer) |
| Accounts receivable | 3.29% | 49.00% | Pass(45.7pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
MSCI M-Series Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 13.59% | 33.33% | Pass(19.7pp buffer) |
| Cash + interest-bearing securities | 2.98% | 33.33% | Pass(30.3pp buffer) |
| Accounts receivable | 6.28% | 49.00% | Pass(42.7pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from SYK's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $25.1B | 2026-06-30 | Revenues |
| Interest-bearing debtShort and long-term borrowings | $14.9B | 2026-06-30 | DebtLongtermAndShorttermCombinedAmount |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $3.4B | 2026-06-30 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
| Total assetsBalance sheet total | $47.9B | 2026-06-30 | Assets |
| Market capDenominator for AAOIFI | $106.0B | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $130.7B | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $136.6B | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $0 | 2026-06-30 | no interest-income tag reported in 3+ years (treated as $0) |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
Sources
Filing information. Balance sheet as of 2026-06-30. Income statement as of 2026-06-30. Screened 2026-09-09.
A newer filing exists: our EDGAR watch has seen one since this screen and it is queued for re-screening. The figures below are from the filings named, not the newer one.
Filing links appear after the next screen: this row was screened before filing citations were recorded.
-
Total assets$47.9B
Assets· balance sheet as of 2026-06-30 -
Interest-bearing debt$14.9B
DebtLongtermAndShorttermCombinedAmount· balance sheet as of 2026-06-30 -
Cash and interest-bearing securities$3.4B
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents· balance sheet as of 2026-06-30 -
Receivables$3.7B
AccountsReceivableNetCurrent· balance sheet as of 2026-06-30 -
Revenue$25.1B
Revenues· income statement as of 2026-06-30 -
Interest income (non-permissible)$0
no interest-income tag reported in 3+ years (treated as $0)· income statement as of 2026-06-30 -
Market cap$106.0BMarket-data quote at screen time, 2026-09-09 · not a filing figure, so no link
What changed, and when
Verdict history for SYK. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for SYK has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
Tracked since 2026-09-07.
Revenue by business segment
How SYK’s $25.1B of revenue for the fiscal year 2025-01-01 to 2025-12-31 splits across what it sells, as the company tags it in its own 10-K. Where a reported segment is broken down further by product, the products are shown under it.
| Segment | Share | Revenue |
|---|---|---|
| MedSurg and Neurotechnology › Medical | 16.7% | $4.2B |
| Orthopaedics › Trauma and Extremities | 15.7% | $3.9B |
| MedSurg and Neurotechnology › Endoscopy | 15.2% | $3.8B |
| MedSurg and Neurotechnology › Instruments | 12.7% | $3.2B |
| Orthopaedics › Knees | 10.6% | $2.7B |
| MedSurg and Neurotechnology › Neuro Cranial | 9.9% | $2.5B |
| MedSurg and Neurotechnology › Neurovascular | 7.8% | $2.0B |
| Orthopaedics › Hips | 7.4% | $1.9B |
| Orthopaedics › Other | 3.2% | $815.0M |
| Orthopaedics › Spine | 0.7% | $185.0M |
These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.
Source: 10-K filed 2026-02-11 (accession 0000310764-26-000010), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.
What would change the status
The headline verdict is the majority of the decided ratio standards — 7 pass and 0 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-06-30; market cap as stored on 2026-09-09.
Within 3 points of the line
- Usmani debt ratio: 0.8pp buffer
- MSCI Islamic debt ratio: 1.1pp buffer
- FTSE Shariah debt ratio: 2.2pp buffer
FTSE Shariah, MSCI Islamic, Usmani are within 3 points of their line. Even if they all crossed, the majority verdict would stay Compliant.
The ratios that move with the share price
AAOIFI's debt ratio (14.6% against a 30% line) would only fail if the market cap fell by 51%, to $51.5B. At the 2026-11-18 close it would read 12.6%.
AAOIFI's investments ratio (3.2% against a 30% line) would only fail if the market cap fell by 89%, to $11.3B. At the 2026-11-18 close it would read 2.8%.
Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.
Shariah-compliant alternatives
Compliant companies in Medical Devices listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| ABTAbbott Laboratories | $201.9B | — |
| MDTMedtronic Plc | $117.8B | — |
| BSXBoston Scientific Corp. | $71.0B | — |
| EWEdwards Lifesciences Corp | $52.2B | — |
| DXCMDexcom Inc | $34.4B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Funds that hold SYK
24 of the 239 funds whose filed holdings we currently hold own SYK shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns SYK.
Shariah funds| Fund | SYK in fund | Fund compliant by weight |
|---|---|---|
| MNZL Manzil Russell Halal USA Broad Market ETF | 0.39% | 88% |
| SPUS SP Funds S&P 500 Sharia Industry Exclusions ETF | 0.29% | 79% |
| HLAL Wahed FTSE USA Shariah ETF | 0.28% | 72% |
Widely held U.S. index funds. If you own one, you own SYK through it. None of them is a Shariah fund; the last column is our look-through of each.
| Fund | SYK in fund | Fund compliant by weight |
|---|---|---|
| RSP Invesco S&P 500 Equal Weight ETF | 0.20% | 44% |
| SPY | 0.17% | 56% |
| VOO VANGUARD 500 INDEX FUND | 0.17% | 56% |
| SPYM State Street(R) SPDR(R) Portfolio S&P 500(R) ETF | 0.17% | 56% |
| IVV iShares Core S&P 500 ETF | 0.17% | 56% |
| VUG VANGUARD GROWTH INDEX FUND | 0.17% | 63% |
| VTI VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.15% | 54% |
| SCHB Schwab U.S. Broad Market ETF | 0.15% | 53% |
| ITOT iShares Core S&P Total U.S. Stock Market ETF | 0.15% | 54% |
| Fund | SYK in fund | Fund compliant by weight |
|---|---|---|
| PRBLX Parnassus Core Equity Fund | 1.86% | 61% |
| QUERX AQR Large Cap Defensive Style Fund | 0.81% | not computed |
| ESGG FlexShares STOXX Global ESG Select Index Fund | 0.42% | 58% |
| QCGLPX College Retirement Equities Fund - Global Equities Account | 0.19% | 57% |
| USPX Franklin U.S. Equity Index ETF | 0.17% | 56% |
| USEW Cambria US EW ETF | 0.17% | not computed |
| QDPL Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF | 0.16% | 48% |
| TEIHX Nuveen Equity Index Fund | 0.15% | 51% |
| REAYX Equity Income Fund | 0.11% | 33% |
| AVUS Avantis U.S. Equity ETF | 0.07% | 49% |
2 more funds
Sorted by SYK’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names SYK once, so a bond is not counted as the shares; 3 more funds name SYK in a way we cannot separate from its bonds, and are not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Terry Smith | Fundsmith | $736M | 5.7% | 2026-09-30 |
| Al Gore | Generation Investment Management | $380M | 4.0% | 2026-09-30 |
| Jeremy Grantham | GMO | $369M | 0.8% | 2026-09-30 |
| David Shaw | D. E. Shaw & Co. | $217M | 0.1% | 2026-09-30 |
| Ken Griffin | Citadel Advisors | $156M | 0.0% | 2026-09-30 |
| Saturna Capital | Amana Mutual Funds Trust | $150M | 1.8% | 2026-09-30 |
| Diamond Hill | Diamond Hill Capital Management | $142M | 1.5% | 2026-09-30 |
| Israel Englander | Millennium Management | $112M | 0.0% | 2026-09-30 |
| Ken Fisher | Fisher Asset Management | $104M | 0.0% | 2026-09-30 |
| Jensen Investment Management | Jensen Investment Management | $97M | 3.1% | 2026-09-30 |
| Steven Cohen | Point72 Asset Management | $45M | 0.0% | 2026-09-30 |
| Paul Tudor Jones | Tudor Investment Corp | $29M | 0.0% | 2026-09-30 |
| Baillie Gifford | Baillie Gifford & Co | $17M | 0.0% | 2026-09-30 |
| Joel Greenblatt | Gotham Asset Management | $16M | 0.0% | 2026-09-30 |
| Jefferies | Jefferies Financial Group | $7M | 0.1% | 2026-09-30 |
| Ray Dalio | Bridgewater Associates | $3M | 0.0% | 2026-09-30 |
| Mario Gabelli | GAMCO Investors | $3M | 0.0% | 2026-09-30 |
| Wahed Invest | Wahed Invest LLC | $3M | 0.3% | 2026-06-30 |
| Mairs & Power | Mairs & Power | $1M | 0.0% | 2026-09-30 |
| Sallie Krawcheck | Ellevest | $1M | 0.1% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 56.30 | NEUTRAL |
| Stochastic %K (14) | 54.40 | NEUTRAL |
| CCI (20) | 31.53 | NEUTRAL |
| Williams %R (14) | -45.60 | NEUTRAL |
| MACD (12,26,9) | -1.16 | SELL |
| ROC (10) | -6.14 | SELL |
| Momentum (10) | -20.86 | SELL |
| EMA (10) | 316.32 | BUY |
| SMA (10) | 319.88 | SELL |
| EMA (20) | 312.39 | BUY |
| SMA (20) | 314.26 | BUY |
| EMA (30) | 308.68 | BUY |
| SMA (30) | 305.80 | BUY |
| EMA (50) | 305.78 | BUY |
| SMA (50) | 293.85 | BUY |
| EMA (100) | 308.24 | BUY |
| SMA (100) | 309.75 | BUY |
| EMA (200) | 319.74 | SELL |
| SMA (200) | 319.71 | SELL |
About SYK
Healthcare · Medical Devices
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Background via Yahoo Finance — informational, not part of the verdict.
Latest Signal — 2026-11-11
Stop 313.77 Now 319.18 Target 330.12
🟡 BULLISH LEAN
The main driver: outperforming the market by 12.3%, RSI in healthy zone. More signals pointing up than down. Not full confluence yet, but the weight of evidence is bullish. Use `!alert SYK [level]` to catch the entry, or `!plan SYK` to size small.
Scores: 3 bullish / 1 bearish
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 64 |
| ⏰ 4H | RANGING | 43 |
| 🕐 1H | BULLISH | 98 |
| ⏱ 15-Min | RANGING | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
BEARISH 0 buys · 1 sells
Recent: Crotty Dylan Bram sold 6102 sh @ $328.61 (2026-08-21)
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.